Clindamycin Phosphate Solution
Product Images NDC 16571-256

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 16571-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clindamycin-60-label.jpg (Clindamycin 60 Label)

Clindamycin Phosphate Topical Solution, USP 1% (Pledgets) by Rising Pharma Holdings, Inc. This prescription drug is a topical solution with a strength of 10 mg/mL, provided in a package containing 60 pledgets. The label includes usage instructions, storage conditions, and manufacturer details.*

FDA Label Image

Clindamycin-structure.jpg (Clindamycin Structure)

Chemical structure diagram of clindamycin phosphate showing its molecular arrangement and bonds.*

FDA Label Image

Clindamycin-table.jpg (Clindamycin Table)

Table presenting the number of patients reporting various emergent adverse events for Clindamycin Phosphate topical formulations: solution (n=553), gel (n=148), and lotion (n=160). Adverse events include burning, itching, dryness, erythema, oiliness/oily skin, and peeling, with some data marked as not recorded or specific to a subset of subjects.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.